Complement C3-Targeted Therapy: Replacing Long-Held Assertions with Evidence-Based Discovery

Overview of attention for article published in Trends in Immunology, June 2017

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (60th percentile)

Mentioned by

twitter: 6 X users

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 44,440 followers.

"Complement C3-Targeted Therapy: Replacing Long-Held Assertions with Evidence-Based Discovery," Trends Immunol → https://t.co/sBXyKwFnSU

RT @TrendsImmuno: Complement-droven diseases: Lambris&co @Penn on C3 blockade opportunities and risk, compared to existing C5 blockade http…

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 2 additional X posts.